Envestnet Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Sell |
64,256
-122,299
| -66% | -$701K | ﹤0.01% | 3915 |
|
|
2025
Q1 | $1.52M | Sell |
186,555
-238,864
| -56% | -$1.95M | ﹤0.01% | 2912 |
|
|
2024
Q4 | $4.01M | Buy |
425,419
+7,204
| +2% | +$67.9K | ﹤0.01% | 2253 |
|
|
2024
Q3 | $4.47M | Sell |
418,215
-32,608
| -7% | -$348K | ﹤0.01% | 2170 |
|
|
2024
Q2 | $4.47M | Buy |
450,823
+16,263
| +4% | +$161K | ﹤0.01% | 2096 |
|
|
2024
Q1 | $5.12M | Buy |
434,560
+19,178
| +5% | +$226K | ﹤0.01% | 1958 |
|
|
2023
Q4 | $5.89M | Buy |
415,382
+21,654
| +5% | +$307K | ﹤0.01% | 1774 |
|
|
2023
Q3 | $4.79M | Buy |
393,728
+248,220
| +171% | +$3.02M | ﹤0.01% | 1828 |
|
|
2023
Q2 | $1.83M | Buy |
145,508
+249
| +0.2% | +$3.13K | ﹤0.01% | 2336 |
|
|
2023
Q1 | $1.61M | Buy |
145,259
+1,182
| +0.8% | +$13.1K | ﹤0.01% | 2337 |
|
|
2022
Q4 | $1.76M | Buy |
144,077
+32,256
| +29% | +$394K | ﹤0.01% | 2251 |
|
|
2022
Q3 | $1.17M | Sell |
111,821
-7,483
| -6% | -$78.1K | ﹤0.01% | 2448 |
|
|
2022
Q2 | $1.28M | Buy |
119,304
+15,506
| +15% | +$166K | ﹤0.01% | 2404 |
|
|
2022
Q1 | $983K | Sell |
103,798
-10,961
| -10% | -$104K | ﹤0.01% | 2682 |
|
|
2021
Q4 | $1.33M | Buy |
114,759
+30,381
| +36% | +$351K | ﹤0.01% | 2437 |
|
|
2021
Q3 | $806K | Buy |
84,378
+12,292
| +17% | +$117K | ﹤0.01% | 2681 |
|
|
2021
Q2 | $695K | Sell |
72,086
-20,682
| -22% | -$199K | ﹤0.01% | 2774 |
|
|
2021
Q1 | $917K | Buy |
92,768
+58,776
| +173% | +$581K | ﹤0.01% | 2454 |
|
|
2020
Q4 | $785K | Buy |
33,992
+2,119
| +7% | +$48.9K | ﹤0.01% | 2399 |
|
|
2020
Q3 | $450K | Buy |
+31,873
| New | +$450K | ﹤0.01% | 2518 |
|
|
2018
Q3 | – | Sell |
-2,130
| Closed | -$33K | – | 1729 |
|
|
2018
Q2 | $33K | Buy |
2,130
+57
| +3% | +$883 | ﹤0.01% | 2313 |
|
|
2018
Q1 | $31K | Sell |
2,073
-103
| -5% | -$1.54K | ﹤0.01% | 2276 |
|
|
2017
Q4 | $31K | Buy |
2,176
+237
| +12% | +$3.38K | ﹤0.01% | 2440 |
|
|
2017
Q3 | $29K | Buy |
+1,939
| New | +$29K | ﹤0.01% | 2429 |
|